Since it appeared that mutations in ZFP36L2 were enriched among rCRCs compared with among nrCRCs, we performed a survival analysis to explore the possibility that mutations in ZFP36L2 were associated with tumor recurrence. The gene discussed is ZFP36L2; the disease is neoplasm.